1
|
Yoo JG, Lee SJ, Nam EJ, No JH, Park JY, Song JY, Shin SJ, Yun BS, Park ST, Lee SH, Suh DH, Kim YB, Lee TS, Bae JM, Lee KH. Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines. J Gynecol Oncol 2024; 35:e44. [PMID: 38389404 PMCID: PMC10948982 DOI: 10.3802/jgo.2024.35.e44] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Revised: 12/24/2023] [Accepted: 12/25/2023] [Indexed: 02/24/2024] Open
Abstract
This fifth revised version of the Korean Society of Gynecologic Oncology practice guidelines for the management of cervical cancer incorporates recent research findings and changes in treatment strategies based on version 4.0 released in 2020. Each key question was developed by focusing on recent notable insights and crucial contemporary issues in the field of cervical cancer. These questions were evaluated for their significance and impact on the current treatment and were finalized through voting by the development committee. The selected key questions were as follows: the efficacy and safety of immune checkpoint inhibitors as first- or second-line treatment for recurrent or metastatic cervical cancer; the oncologic safety of minimally invasive radical hysterectomy in early stage cervical cancer; the efficacy and safety of adjuvant systemic treatment after concurrent chemoradiotherapy in locally advanced cervical cancer; and the oncologic safety of sentinel lymph node mapping compared to pelvic lymph node dissection. The recommendations, directions, and strengths of this guideline were based on systematic reviews and meta-analyses, and were finally confirmed through public hearings and external reviews. In this study, we describe the revised practice guidelines for the management of cervical cancer.
Collapse
Affiliation(s)
- Ji Geun Yoo
- Department of Obstetrics and Gynecology, Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Korea
| | - Sung Jong Lee
- Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea
| | - Eun Ji Nam
- Department of Obstetrics and Gynecology, Institute of Women's Medical Life Science, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Jae Hong No
- Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Jeong Yeol Park
- Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
| | - Jae Yun Song
- Department of Obstetrics and Gynecology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
| | - So-Jin Shin
- Department of Obstetrics and Gynecology, Keimyung University Dongsan Medical Center, Daegu, Korea
| | - Bo Seong Yun
- Department of Obstetrics and Gynecology, CHA Ilsan Medical Center, CHA University, Goyang, Korea
| | - Sung Taek Park
- Department of Obstetrics and Gynecology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea
| | - San-Hui Lee
- Department of Obstetrics and Gynecology, Wonju Severance Christian Hospital, Yonsei University College of Medicine, Wonju, Korea
| | - Dong Hoon Suh
- Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Yong Beom Kim
- Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Taek Sang Lee
- Department of Obstetrics and Gynecology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea
| | - Jae Man Bae
- Department of Obstetrics and Gynecology, Hanyang University Medical Center, Seoul, Korea
| | - Keun Ho Lee
- Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
| |
Collapse
|
2
|
Wu X, Yu H, Bai Y, Hou Y, Lou W, Wang X, Zhu T, Zhang Y, Hu W, Xue X, Zhu Z, Xiang L, Li J, Fang X, Gao S, Feng H, Diao W, Zhang H, Du M, Yan W, Qiu L, Feng H, Zhu S, Du Y, Jiang H. A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IB3 and IIA2): study protocol of the LAUNCH 3 trial. Trials 2023; 24:542. [PMID: 37592299 PMCID: PMC10436641 DOI: 10.1186/s13063-023-07573-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2022] [Accepted: 08/04/2023] [Indexed: 08/19/2023] Open
Abstract
BACKGROUND Cervical cancer is and will remain to be an important health problem in China, especially with an increasing proportion of younger patients who has more specific needs. In China, surgery to remove tumor burden followed by postoperative treatment with radiotherapy and chemotherapy based on clinicopathologic factors may be the best choice for stages IB3 and IIA2 patients. Radical hysterectomy in cervical cancer has been a classic landmark surgery in gynecology. The current trial is designed to evaluate whether there is a difference between laparoscopic RH and abdominal RH in cervical cancer (stages IB3 and IIA2) patient survival under stringent operation standards and consistent surgical oncologic principles. This paper reports the rationale, design, and implementation of the trial. METHODS/DESIGN This is an investigator-initiated, prospective, randomized, open, blinded endpoint (PROBE) controlled trial. A total of 1104 patients with stage IB3 and IIA2 cervical cancer will be enrolled over a period of 3 years. Patients are randomized (1:1) to either the laparoscopic RH or the abdominal RH group. Patients will then be followed up for at least 5 years. The primary end point will be 5-year overall survival, and secondary endpoints include 5-year progression-free survival, recurrence, and quality of life measurements. DISCUSSION The study results will provide more convincing evidence-based information for stages IB3 and IIA2 cervical cancer patients and their gynecologic cancer surgeons in their choice of surgical method. TRIAL REGISTRATION ClinicalTrials.gov, NCT04939831 , retrospectively registered on 25 June 2021.
Collapse
Affiliation(s)
- Xin Wu
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Hailin Yu
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Yongrui Bai
- Shanghai Jiao Tong University School of Medicine, Renji Hospital, Shanghai, China
| | - Yanli Hou
- Shanghai Jiao Tong University School of Medicine, Renji Hospital, Shanghai, China
| | - Weihua Lou
- Shanghai Jiao Tong University School of Medicine, Renji Hospital, Shanghai, China
| | - Xipeng Wang
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Tao Zhu
- Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
| | - Yuyang Zhang
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
| | - Weiguo Hu
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Xiaohong Xue
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Zhiling Zhu
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Libing Xiang
- Zhongshan Hospital Affiliated to Fudan University, Shanghai, China
| | - Jiarui Li
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Xuhong Fang
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Shujun Gao
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Hua Feng
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Wenjing Diao
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Hongwei Zhang
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Ming Du
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Weili Yan
- Children's Hospital of Fudan University, Shanghai, China
| | - Ling Qiu
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Hao Feng
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Shurong Zhu
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China
| | - Yan Du
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China.
| | - Hua Jiang
- Obstetrics and Gynecology Hospital, Fudan University, 128 Shenyang Rd 200090, Shanghai, China.
| |
Collapse
|